REPROCELL Employee Directory
Biotechnology ResearchKanagawa, Japan51-200 Employees
REPROCELL operates in biotechnology research and supports nearly the entire workflow of stem cell research and preclinical drug development. Its offerings include access to human tissues via BioServe and tissue testing through Biopta, alongside stem cell culture media, reprogramming technologies, reagents, and iPSC-derived cell types supplied through Stemgent. With in-depth knowledge of stem cell biology, bioengineered tissue models, cell differentiation, and pharmacology, the company provides the tools and services needed to advance regenerative medicine and related drug development efforts. A newly formed REPROCELL Medical unit focuses on developing reagents and services for clinical-grade products and regenerative medicine applications, while its laboratories perform diagnostic testing for tissue compatibility and other biomarkers. The firm also operates a GMP iPSC master cell bank manufacturing service. Based in Yokohama, Kanagawa, Japan, REPROCELL has a history that includes a JASDAQ listing in 2013 and acquisitions of Stemgent, BioServe, Reinnervate, and Biopta in subsequent years.
1-888-653-2347 
support@leadiq.com 
